Leptospirosis patient registry study in hospitals
Part of Infections clinical trials.
This study records information from people who have invasive (spreading) leptospirosis, a bacterial infection. The goal is to better understand how the disease presents and spreads, which can help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lab or tissue test evidence of invasive (spreading) leptospirosis, or doctors think it is spreading leptospirosis based on symptoms
- Your illness shows signs of disseminated (spreading) infection
- If you are being enrolled as a comparison person (case-control), you will be selected from the same hospital and matched by age/demographics, other illnesses, and hospital stay length
- You do not only have non-invasive leptospirosis (infection only on the surface or colonization)
- You do not have leptospirosis evidence with no signs of it spreading
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body responds to leptospirosis infection to improve diagnosis and treatment. It is for people with fever and possible leptospirosis, as well as healthy volunteers.
This trial tests a structured set of hospital treatments (“care bundle”) for adults with suspected leptospirosis, a serious infection often linked to flood water exposure. It may help by improving how quickly and consistently key care steps are delivered in the hospital.
This study examines how your immune system responds to leptospirosis (a bacterial infection) by analyzing blood samples. Researchers are testing a new approach to help your body fight the infection more effectively.
This trial tests ways to prevent early and late complications of leptospirosis, a bacterial infection. It aims to offer treatments that may reduce the risk of serious problems like kidney failure or breathing difficulties.
This study collects information from people with leptomeningeal disease, a condition where cancer spreads to the lining of the brain and spinal cord. By joining, you help researchers learn more about this disease and how it affects people.
This study compares two antibiotic schedules (3 days vs 7 days) for adults with mild leptospirosis. It aims to find out if a shorter course works as well and is easier to tolerate.
Hear when a new Leptospirosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.